Pazopanib in Combination With Capecitabine in Patients With Metastatic Breast Cancer (PazoX)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2011 by German Breast Group.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by (Responsible Party):
German Breast Group
ClinicalTrials.gov Identifier:
NCT01498458
First received: December 21, 2011
Last updated: April 16, 2012
Last verified: December 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: May 2013
  Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)